Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Intellia Therapeutics Reports Promising Phase 1 Trial Results for Nexiguran Ziclumeran in ATTR Amyloidosis Quiver Quantitative, Inc. - Sat Nov 16, 7:28PM CST

Intellia Therapeutics announces positive Phase 1 trial results for nex-z in ATTR amyloidosis, indicating significant TTR reduction and disease stabilization.Quiver AI SummaryIntellia Therapeutics announced...

NTLA : 14.06 (+7.16%)
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis GlobeNewswire - Sat Nov 16, 9:16AM CST

NTLA : 14.06 (+7.16%)
Author
3 Fast-Growing Stocks Analysts See Doubling in Price MarketBeat - Mon Nov 11, 6:14AM CST

Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.

IMCR : 32.04 (-1.17%)
GHRS : 9.69 (-11.51%)
NTLA : 14.06 (+7.16%)
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress GlobeNewswire - Thu Nov 7, 6:30AM CST

NTLA : 14.06 (+7.16%)
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day? Motley Fool - Wed Nov 6, 8:45AM CST

There's nothing bearish at all about what it reported recently.

NTLA : 14.06 (+7.16%)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Nov 5, 3:01PM CST

NTLA : 14.06 (+7.16%)
This Beaten-Down Stock Could Soar by 354%, According to Wall Street Motley Fool - Mon Nov 4, 7:00AM CST

Maybe the Street is a bit too optimistic on this one.

NTLA : 14.06 (+7.16%)
Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024 GlobeNewswire - Thu Oct 31, 6:30AM CDT

NTLA : 14.06 (+7.16%)
12 High-Growth Stocks That Could Deliver Parabolic Returns Motley Fool - Mon Oct 28, 9:00AM CDT

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 146.34 (+0.31%)
NVTS : 2.0150 (+10.11%)
VRTX : 449.55 (-0.37%)
RKLB : 22.11 (+9.56%)
LUNR : 13.91 (+15.24%)
SERV : 8.53 (-2.40%)
ACHR : 5.79 (+14.43%)
TSLA : 340.12 (-0.56%)
CRSP : 46.25 (-2.14%)
SOUN : 7.04 (+9.32%)
APLD : 9.48 (+8.22%)
TM : 173.48 (+0.33%)
Why Intellia Therapeutics Stock Plummeted by 20% Today Motley Fool - Thu Oct 24, 6:22PM CDT

Seemingly encouraging results from the lab were met with some notable skepticism.

NTLA : 14.06 (+7.16%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 47 minutes ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot